{"id":"detemir-insulin","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Lipodystrophy"}]},"_chembl":null,"_dailymed":{"setId":"d38d65c1-25bf-401d-9c7e-a2c3222da8af","title":"LEVEMIR (INSULIN DETEMIR) INJECTION, SOLUTION [NOVO NORDISK]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Detemir is a modified human insulin analog with a fatty acid chain attached, which allows it to bind to albumin in the bloodstream and be released slowly, providing a steady basal insulin level over approximately 24 hours. It works by activating insulin receptors on muscle, fat, and liver cells to increase glucose uptake and reduce hepatic glucose production, thereby lowering blood glucose levels in diabetic patients.","oneSentence":"Detemir insulin is a long-acting basal insulin that binds to the insulin receptor to lower blood glucose by promoting glucose uptake and storage in cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:40:13.001Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT02556840","phase":"NA","title":"Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-04-25","conditions":"Maturity-Onset Diabetes of the Young","enrollment":46},{"nctId":"NCT04416269","phase":"PHASE4","title":"Oral Anti Diabetic Agents in the Hospital","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2020-08-07","conditions":"Diabetes Mellitus","enrollment":255},{"nctId":"NCT01239550","phase":"NA","title":"Insulin Detemir in Obesity Management","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University","startDate":"2011-04","conditions":"Diabetes, Obesity","enrollment":240},{"nctId":"NCT06445946","phase":"PHASE4","title":"DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-08-01","conditions":"Gestational Diabetes Mellitus, Pregnancy, High Risk","enrollment":1572},{"nctId":"NCT06685185","phase":"PHASE1","title":"A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes","status":"RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2024-11-12","conditions":"Diabetes Mellitus, Type 1","enrollment":154},{"nctId":"NCT05922033","phase":"PHASE4","title":"Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes (EMPOWER)","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2023-10-19","conditions":"Gestational Diabetes Mellitus, Pregnancy in Diabetic, Pregnancy, High Risk","enrollment":56},{"nctId":"NCT04974528","phase":"PHASE3","title":"Afrezza® INHALE-1 Study in Pediatrics","status":"COMPLETED","sponsor":"Mannkind Corporation","startDate":"2021-09-29","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":319},{"nctId":"NCT02496780","phase":"PHASE2, PHASE3","title":"The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis Patients","status":"TERMINATED","sponsor":"University of Minnesota","startDate":"2015-08","conditions":"Cystic Fibrosis","enrollment":65},{"nctId":"NCT06419803","phase":"NA","title":"Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2024-09-01","conditions":"Gestational Diabetes, Pregnancy Related","enrollment":430},{"nctId":"NCT06419777","phase":"NA","title":"Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2024-09-01","conditions":"Gestational Diabetes, Pregnancy Related","enrollment":430},{"nctId":"NCT02871089","phase":"NA","title":"Closed Loop From Onset in Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cambridge","startDate":"2017-01","conditions":"Diabetes Mellitus, Type 1 Diabetes","enrollment":96},{"nctId":"NCT02048189","phase":"PHASE4","title":"Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 Diabetes","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2012-03-08","conditions":"Patient With Type 2 Diabetes Treated With Insulin Using a Baseline/Bolus Strategy","enrollment":14},{"nctId":"NCT00455858","phase":"PHASE4","title":"Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in Korea","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":87},{"nctId":"NCT02518945","phase":"PHASE3","title":"Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes","status":"COMPLETED","sponsor":"University at Buffalo","startDate":"2015-08","conditions":"Type 1 Diabetes Mellitus","enrollment":26},{"nctId":"NCT00671008","phase":"","title":"Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-12","conditions":"Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":400},{"nctId":"NCT00383877","phase":"PHASE3","title":"Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2006-09","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":263},{"nctId":"NCT00447382","phase":"PHASE3","title":"Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-03","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":330},{"nctId":"NCT00655200","phase":"","title":"Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2008-02","conditions":"Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":2286},{"nctId":"NCT00313742","phase":"PHASE4","title":"The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2006-04","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":51},{"nctId":"NCT00504673","phase":"PHASE3","title":"Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2005-04","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":277},{"nctId":"NCT00521690","phase":"PHASE4","title":"The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OAD","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2006-12","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":25},{"nctId":"NCT00687063","phase":"","title":"Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2008-04","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":10008},{"nctId":"NCT00701155","phase":"","title":"Observational Study to Evaluate the Safety While Using Levemir®","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-07","conditions":"Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":3593},{"nctId":"NCT05124457","phase":"PHASE2","title":"DETERMINE: Detemir vs NPH","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2022-02-01","conditions":"Gestational Diabetes, Diabetes Mellitus, Type 2","enrollment":336},{"nctId":"NCT00506662","phase":"PHASE4","title":"Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2007-07","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":86},{"nctId":"NCT05161429","phase":"","title":"BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes","status":"UNKNOWN","sponsor":"Brigham and Women's Hospital","startDate":"2021-07-01","conditions":"Diabetes Mellitus, Type 2","enrollment":550000},{"nctId":"NCT00788840","phase":"PHASE4","title":"Detemir Energy Expenditure Study","status":"COMPLETED","sponsor":"University of Surrey","startDate":"2008-01","conditions":"Type 2 Diabetes Mellitus, Obesity","enrollment":30},{"nctId":"NCT01100892","phase":"PHASE3","title":"Cystic Fibrosis - Insulin Deficiency, Early Action","status":"COMPLETED","sponsor":"Sydney Children's Hospitals Network","startDate":"2010-12","conditions":"Cystic Fibrosis, Diabetes","enrollment":100},{"nctId":"NCT03377699","phase":"PHASE3","title":"Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2017-11-22","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":225},{"nctId":"NCT05134987","phase":"PHASE1","title":"A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It Works","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2021-12-01","conditions":"Diabetes Mellitus, Type 1","enrollment":30},{"nctId":"NCT02967224","phase":"PHASE4","title":"A \"Real World\" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to \"Standard of Care\" Basal Insulins in Insulin Naïve Patients Initiating Insulin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-11-05","conditions":"Diabetes Mellitus, Type 2","enrollment":705},{"nctId":"NCT02967211","phase":"PHASE4","title":"A \"Real World\" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to \"Standard of Care\" Basal Insulin in Patients Already Using Basal Insulin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-12-21","conditions":"Diabetes Mellitus, Type 2","enrollment":609},{"nctId":"NCT00591227","phase":"PHASE4","title":"Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2008-05","conditions":"Type 2 Diabetes Mellitus","enrollment":176},{"nctId":"NCT01186003","phase":"NA","title":"Effectiveness of Adding Subcutaneous Long-Acting Detemir to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2010-08","conditions":"Diabetes","enrollment":30},{"nctId":"NCT03620890","phase":"PHASE4","title":"Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-09-04","conditions":"Diabetes Mellitus, Type 2","enrollment":108},{"nctId":"NCT01269034","phase":"PHASE4","title":"New Onset Type 1 Diabetes: Role of Exenatide","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2010-12","conditions":"Type 1 Diabetes","enrollment":13},{"nctId":"NCT02922179","phase":"","title":"Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics","status":"COMPLETED","sponsor":"Biologics & Biosimilars Collective Intelligence Consortium","startDate":"2011-01-01","conditions":"Diabetes","enrollment":103951},{"nctId":"NCT04965051","phase":"NA","title":"Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2021-08","conditions":"Type 1 Diabetes Mellitus With Diabetic Gastroparesis, HbA1c, Time in Range","enrollment":40},{"nctId":"NCT03001323","phase":"NA","title":"Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis","status":"TERMINATED","sponsor":"Hennepin Healthcare Research Institute","startDate":"2017-01","conditions":"Diabetes Mellitus","enrollment":27},{"nctId":"NCT01654120","phase":"PHASE4","title":"Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics","status":"COMPLETED","sponsor":"Mountain Diabetes and Endocrine Center","startDate":"2011-12","conditions":"Diabetes Mellitus, Type II","enrollment":37},{"nctId":"NCT01616784","phase":"PHASE3","title":"The REPOSE (Relative Effectiveness of Pumps Over MDI and Structured Education) Trial","status":"COMPLETED","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2011-11","conditions":"Type 1 Diabetes","enrollment":267},{"nctId":"NCT01595646","phase":"PHASE2","title":"Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2011-11","conditions":"Alzheimer's Disease, Mild Cognitive Impairment","enrollment":37},{"nctId":"NCT02846233","phase":"NA","title":"Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2016-08","conditions":"Type 2 Diabetes Mellitus","enrollment":22},{"nctId":"NCT04034524","phase":"","title":"Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin","status":"UNKNOWN","sponsor":"Brigham and Women's Hospital","startDate":"2019-05-01","conditions":"Diabetes Mellitus, Type 2","enrollment":20000},{"nctId":"NCT04222348","phase":"PHASE3","title":"MeDiGes Study: Metformine Use in Gestational Diabetes","status":"UNKNOWN","sponsor":"Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud","startDate":"2016-10-26","conditions":"Diabetes, Gestational, Perinatal Disorder, Puerperal Disorder","enrollment":200},{"nctId":"NCT02556918","phase":"PHASE4","title":"Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery","status":"COMPLETED","sponsor":"Emory University","startDate":"2016-01","conditions":"Hyperglycemia","enrollment":202},{"nctId":"NCT01892319","phase":"","title":"An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2013-09-30","conditions":"Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":2446},{"nctId":"NCT01966978","phase":"PHASE4","title":"The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2014-11","conditions":"Diabetes Mellitus, Type 2, Diabetes","enrollment":157},{"nctId":"NCT00564018","phase":"NA","title":"Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH","status":"TERMINATED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2006-09","conditions":"Type 1 Diabetes","enrollment":33},{"nctId":"NCT02824510","phase":"NA","title":"Evaluation of Glycemic Changes During Exercise in Children With Type 1 Diabetes","status":"COMPLETED","sponsor":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","startDate":"2014-08","conditions":"Type 1 Diabetes","enrollment":24},{"nctId":"NCT02451137","phase":"PHASE4","title":"A \"Real World\" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-06-16","conditions":"Diabetes Mellitus, Type 2","enrollment":3304},{"nctId":"NCT01232946","phase":"NA","title":"Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake","status":"COMPLETED","sponsor":"Indiana University","startDate":"2012-01","conditions":"Type 2 Diabetes","enrollment":30},{"nctId":"NCT03960814","phase":"","title":"A Study of All-Cause and Cardiovascular Mortality in Type 2 Diabetes Patients Using Basal Insulin Detemir and Glargine","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2019-05-21","conditions":"Diabetes Mellitus, Type 2","enrollment":12847},{"nctId":"NCT01513473","phase":"PHASE3","title":"A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2012-01-16","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":350},{"nctId":"NCT01831765","phase":"PHASE3","title":"Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2013-08-26","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":1290},{"nctId":"NCT01850615","phase":"PHASE3","title":"Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2013-09-23","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":323},{"nctId":"NCT01835431","phase":"PHASE3","title":"A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2013-10-17","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":362},{"nctId":"NCT03959865","phase":"","title":"GLP-1 REceptor Agonists and Real World EvIdeNce","status":"UNKNOWN","sponsor":"University of Padova","startDate":"2018-12-19","conditions":"Type 2 Diabetes","enrollment":6000},{"nctId":"NCT03908762","phase":"NA","title":"mHealth Titration and Management","status":"UNKNOWN","sponsor":"Amalgam Rx, Inc.","startDate":"2019-01-01","conditions":"Diabetes Mellitus, Type 2, Diabetic Complication","enrollment":40},{"nctId":"NCT00906529","phase":"PHASE4","title":"Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin","status":"WITHDRAWN","sponsor":"University of Texas Southwestern Medical Center","startDate":"2009-05","conditions":"Type 2 Diabetes","enrollment":""},{"nctId":"NCT02131272","phase":"PHASE3","title":"A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2014-06-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":42},{"nctId":"NCT02033889","phase":"PHASE3","title":"A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2013-12-13","conditions":"Type 2 Diabetes Mellitus","enrollment":621},{"nctId":"NCT00322257","phase":"PHASE3","title":"Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2006-05-01","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":596},{"nctId":"NCT01281605","phase":"NA","title":"Comparison of Two Titration Programs of Adding Insulin Detemir to OADs in Poorly Controlled Type 2 Diabetes","status":"COMPLETED","sponsor":"Mackay Memorial Hospital","startDate":"2011-01","conditions":"Type 2 Diabetes","enrollment":181},{"nctId":"NCT02219750","phase":"PHASE4","title":"Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"Mackay Memorial Hospital","startDate":"2013-08","conditions":"Diabetes","enrollment":181},{"nctId":"NCT00564395","phase":"PHASE4","title":"Detemir: Role in Type 1 Diabetes","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2007-08","conditions":"Type 1 Diabetes Mellitus","enrollment":18},{"nctId":"NCT02741687","phase":"PHASE4","title":"Sitagliptin in Non-Diabetic Patients Undergoing General Surgery","status":"COMPLETED","sponsor":"Emory University","startDate":"2016-06","conditions":"Hyperglycemia","enrollment":80},{"nctId":"NCT01269047","phase":"PHASE4","title":"Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2009-08","conditions":"Type 1 Diabetes","enrollment":37},{"nctId":"NCT00639626","phase":"PHASE2, PHASE3","title":"Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)","status":"TERMINATED","sponsor":"Nationwide Children's Hospital","startDate":"2008-08","conditions":"Cystic Fibrosis Related Diabetes","enrollment":6},{"nctId":"NCT00659165","phase":"NA","title":"Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2008-04","conditions":"Diabetes Mellitus","enrollment":10},{"nctId":"NCT02933645","phase":"NA","title":"Effects of Intranasal Insulin Administration on Tissue Specific Insulin Sensitivity","status":"COMPLETED","sponsor":"Turku University Hospital","startDate":"2016-04","conditions":"Insulin Resistance","enrollment":10},{"nctId":"NCT02302716","phase":"PHASE3","title":"A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2014-12","conditions":"Diabetes Mellitus, Type 2","enrollment":493},{"nctId":"NCT03220425","phase":"PHASE3","title":"Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2001-02-01","conditions":"Diabetes Mellitus, Type 1","enrollment":752},{"nctId":"NCT00605020","phase":"PHASE3","title":"Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2003-12-02","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":719},{"nctId":"NCT03180281","phase":"NA","title":"Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β Cell","status":"UNKNOWN","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2017-07-01","conditions":"Type 2 Diabetes Mellitus","enrollment":135},{"nctId":"NCT00117780","phase":"PHASE4","title":"Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2005-06","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":520},{"nctId":"NCT01837680","phase":"NA","title":"Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy","status":"COMPLETED","sponsor":"St. Luke's-Roosevelt Hospital Center","startDate":"2013-03","conditions":"Diabetes, Gestational, Diabetes, Type 2","enrollment":105},{"nctId":"NCT01232491","phase":"PHASE4","title":"Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2010-10-29","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":611},{"nctId":"NCT01798706","phase":"PHASE3","title":"Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Sanofi","startDate":"2013-06","conditions":"Type 2 Diabetes","enrollment":350},{"nctId":"NCT02767596","phase":"PHASE4","title":"Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog","status":"TERMINATED","sponsor":"Laniado Hospital","startDate":"2016-07-12","conditions":"Diabetes Mellitus Type 2","enrollment":2},{"nctId":"NCT00773279","phase":"PHASE3","title":"Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2008-09","conditions":"Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":242},{"nctId":"NCT00978627","phase":"PHASE3","title":"Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-08","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":548},{"nctId":"NCT01486966","phase":"PHASE4","title":"Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2011-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":58},{"nctId":"NCT00789191","phase":"PHASE3","title":"Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2008-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":222},{"nctId":"NCT00537303","phase":"PHASE4","title":"Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-10","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":296},{"nctId":"NCT00509925","phase":"PHASE4","title":"Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2007-07","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":23},{"nctId":"NCT00474045","phase":"PHASE3","title":"Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-05","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":470},{"nctId":"NCT00659295","phase":"","title":"Observational Study to Evaluate the Safety of Levemir® in Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2004-06","conditions":"Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":51170},{"nctId":"NCT00909480","phase":"PHASE4","title":"Effect of Insulin Detemir and Insulin Glargine on Blood Glucose Control in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-05","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":457},{"nctId":"NCT00435019","phase":"PHASE3","title":"Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-02","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":348},{"nctId":"NCT00634842","phase":"PHASE4","title":"Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2008-02","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":244},{"nctId":"NCT00184600","phase":"PHASE3","title":"Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2004-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":708},{"nctId":"NCT00856986","phase":"PHASE3","title":"The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-03","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":987},{"nctId":"NCT01074268","phase":"PHASE3","title":"Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2010-02","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":456},{"nctId":"NCT01868542","phase":"PHASE4","title":"A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Without Other Anti-diabetic Drugs (OADs)","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2013-06","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":46},{"nctId":"NCT02811484","phase":"PHASE4","title":"Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes","status":"WITHDRAWN","sponsor":"Weill Medical College of Cornell University","startDate":"2016-06","conditions":"Diabetes Mellitus, Type 2","enrollment":""},{"nctId":"NCT00841087","phase":"PHASE2","title":"Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-01","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":65},{"nctId":"NCT00331604","phase":"PHASE3","title":"Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2006-08-31","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":618},{"nctId":"NCT00605137","phase":"PHASE3","title":"Safety of Insulin Detemir in Children With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2004-05-21","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":83},{"nctId":"NCT00595374","phase":"PHASE3","title":"Efficacy and Safety of Insulin Detemir in Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2003-12-02","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":114}],"_emaApprovals":[],"_faersSignals":[{"count":8,"reaction":"BLOOD GLUCOSE INCREASED"},{"count":5,"reaction":"HYPOGLYCAEMIA"},{"count":4,"reaction":"CEREBROVASCULAR ACCIDENT"},{"count":4,"reaction":"DIARRHOEA"},{"count":4,"reaction":"DRUG INEFFECTIVE"},{"count":4,"reaction":"EXTRADURAL HAEMATOMA"},{"count":4,"reaction":"FALL"},{"count":4,"reaction":"HEADACHE"},{"count":3,"reaction":"ANAEMIA VITAMIN B12 DEFICIENCY"},{"count":3,"reaction":"BLOOD GLUCOSE DECREASED"}],"_approvalHistory":[],"publicationCount":53,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Detemir insulin","genericName":"Detemir insulin","companyName":"The University of Texas Health Science Center, Houston","companyId":"the-university-of-texas-health-science-center-houston","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Detemir insulin is a long-acting basal insulin that binds to the insulin receptor to lower blood glucose by promoting glucose uptake and storage in cells. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}